Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) [Phase 3]
A Phase 3 multicenter trial evaluated the efficacy and safety of PEP005 (ingenol mebutate) gel for actinic keratoses on the face or scalp. T…
-
FDA approval · 2012-03-06FDA Approved: IMIQUIMOD — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic imiquimod 5% cream (ANDA 201994) as an original application, expanding access to the dermatology indications…
-
FDA label_change · 2012-02-14FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ZYCLARA (imiquimod) to update the labeling with new or expanded indications.
-
CLINICAL_TRIALS research · 2011-12-08Clinical Trial Update: Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses [NA]
Clinical trial update comparing photodynamic therapy versus CO2 laser therapy for actinic keratosis; no phase information and trial status i…
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients [Phase 2]
Phase 2 trial comparing ALA-mediated photodynamic therapy to vehicle PDT for actinic keratoses and reduction of new non-melanoma skin cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head [Phase 4]
A Phase 4 trial comparing 3 months vs 6 months of Solaraze (diclofenac sodium 3% gel) for actinic keratosis on the face and head. The study …
-
CLINICAL_TRIALS research · 2011-07-29Clinical Trial Update: 5fluorouracil for Advanced Photoaging [Phase 3]
A Phase 3 clinical trial update assessing topical 5-fluorouracil for advanced photoaging, involving conditions photoaging and actinic kerato…
-
FDA label_change · 2011-07-15FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA records a supplemental application for ZYCLARA (imiquimod) from Bausch Health US, LLC, filed to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses [Phase 4]
Clinical trial update on imiquimod 3.75% cream in combination with cryotherapy for hypertrophic actinic keratoses (actinic keratosis) in a P…
-
FDA approval · 2011-04-15FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' imiquimod generic under an Original Application (ANDA 200173) for the same indications as the br…
-
FDA approval · 2011-03-24FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for ZYCLARA (imiquimod) from Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion [Phase 3]
Phase 3 trial evaluating short incubation methyl aminolevulinate photodynamic therapy without occlusion for actinic keratosis; results were …
-
CLINICAL_TRIALS research · 2010-12-06Clinical Trial Update: Phase II AK Study in Organ Transplant Patients [Phase 2]
A Phase II trial update from Clinuvel Pharmaceuticals for actinic keratosis and squamous cell carcinoma in organ transplant recipients; the …
-
FDA approval · 2010-09-07FDA Approved: IMIQUIMOD — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's imiquimod generic (ANDA 078837) for actinic keratosis, superficial basal cell carcinom…
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery [Phase 3]
Phase 3 safety and effectiveness study evaluating an Actinic keratosis treatment following cryosurgery; results were posted in 2010. Sponsor…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream [Phase 2]
This update summarizes the cellular and molecular changes observed during treatment of actinic keratosis with imiquimod 5% cream in a Phase …
-
CLINICAL_TRIALS trial_result · 2010-07-01Clinical Trial Update: Imiquimod and Actinic Keratoses: an Observational Study
This completed observational study evaluated the use of imiquimod in patients with actinic keratosis.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) [Phase 3]
Phase 3 safety and efficacy study of imiquimod cream for actinic keratoses completed. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) [Phase 3]
This document reports the completion and results posting of a Phase 3 study evaluating the safety and effectiveness of imiquimod cream for t…
-
FDA approval · 2010-03-25FDA Approved: ZYCLARA — Original Application (Bausch Health US, LLC)
The FDA approved ZYCLARA (imiquimod) 3.75% cream from Bausch Health US, LLC as an Original Application (NDA022483). The product is approved …
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Bioequivalence Study of Two Imiquimod Cream 5% [Phase 1]
This trial update reports a Phase 1 bioequivalence study comparing two Imiquimod 5% creams for actinic keratosis. The study status is comple…
-
FDA label_change · 2009-07-17FDA Approved: LEVULAN KERASTICK — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for LEVULAN KERASTICK (amino-levulinic acid hydrochloride) to update the labeling.
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Effect of IDEA-070 on Pain and Inflammation Induced by PDT [Phase 2]
A Phase 2 trial evaluated IDEA-070 for reducing pain and inflammation induced by photodynamic therapy in actinic keratosis. The study status…
-
CLINICAL_TRIALS trial_result · 2009-03-10Clinical Trial Update: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis [Phase 3]
Phase 3 randomized, double-blind, parallel-group, vehicle-controlled study comparing three Imiquimod 5% cream regimens to assess therapeutic…
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis [Phase 4]
Open-label Phase 4 safety study evaluating imiquimod 5% cream for large areas of actinic keratosis has completed and results were posted in …